主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CHRS
#3090
Coherus Oncology, Inc. Common Stock
1.740
0
USD
+2.96%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+2.96%
每月变动
+9.43%
6个月变化
+8.07%
年变化
+8.07%
前一天收盘价
1.690
0
Open
1.740
0
Bid
Ask
Low
1.740
0
High
1.740
0
交易量
40
市场
股票
医疗保健
CHRS
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
72.79 M
77.28 M
79.61 M
112.71 M
115.9 M
149.89 M
—
Valuation ratios
Enterprise value
724 M
816.12 M
613.93 M
251.03 M
33.95 M
123.96 M
98.09 M
Price to earnings ratio
10.73
-4.19
-2.26
-1.24
5.52
0.99
2.02
Price to sales ratio
3.05
3.69
3.13
1.15
0.59
3.94
5.11
Price to cash flow ratio
9.41
32.17
2.74
1.69
7.75
1.2
-104.51
Price to book ratio
5.16
12.32
4.81
1.53
1.2
2.73
3.44
Enterprise value to EBITDA ratio
1.83
3.91
6.83
5.75
0.28
57.18
58.84
Profitability ratios
Return on assets %
0.16
0.42
0.61
0.38
0.06
0.65
0.04
Return on equity %
0.47
2.94
2.12
1.23
0.22
2.75
-0.44
Return on invested capital %
270.47
458.6
483.09
271.04
182.25
313.07
—
Gross margin %
92.08
82.36
66.79
38.19
55.97
67.24
268.09
Operating margin %
32.85
80.8
121.72
78.99
41.83
429.51
1 784.54
EBITDA margin %
83.35
63.87
42.6
16.97
44.9
5.14
-1 810.45
Net margin %
27.79
87.92
138.24
92.48
10.68
398.43
2 215.19
Liquidity ratios
Quick ratio
4.97
3.42
2.47
1.24
0.96
1.45
5.31
Current ratio
5.27
3.64
2.75
1.43
1.21
1.47
5.37
Inventory turnover
1.39
1.41
1.83
3.14
1.77
0.38
3.6
Asset turnover
0.76
0.43
0.36
0.46
0.5
0.12
0.1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.45
0.56
0.47
0.36
0.51
—
—
Long term debt to total equity ratio
1.34
3.9
1.64
1.17
1.73
—
—
Per share metrics
Operating cash flow per share
1.85
0.5
3.11
1.86
0.18
1.18
1.19
EBIT per share
4.71
2.72
1.06
0.43
1.03
0.01
-1.59
EBITDA per share
4.75
2.76
1.16
0.46
1.04
0.02
-1.58
Total debt per share
—
—
—
—
—
—
—
Cash per share
6.48
5.53
2.47
1.25
1.1
1.47
5.88
Net current asset value per share
9.19
7.98
4.91
5.05
2.97
1.76
11.68
Tangible book value per share
3.32
1.25
1.68
1.29
0.68
0.13
2.16
Working capital per share
7.45
5.79
3.12
1.53
0.51
0.57
2.81
Book value per share
3.37
1.3
1.77
2.05
1.15
0.52
3.89
新闻
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Coherus BioSciences在Citizens大会上展示战略性肿瘤学转型
Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift
Oppenheimer重申Coherus Biosciences股票评级为跑赢大盘
Oppenheimer reiterates Coherus Biosciences stock rating at Outperform
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates
Coherus BioSciences Q1 每股收益 与预期持平, 营收 低于预期
Coherus BioSciences earnings matched, revenue fell short of estimates
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates
Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates
Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates